Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 344

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 344
---
taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination
by taxing authorities. There were no unrecognized tax benefits as of December 31, 2023 and 2022. The Company recognizes accrued interest
and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties
at December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments,
accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since
inception.

Deferred tax liabilities
and assets are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted
tax rates in effect for the year in which the differences are expected to reverse. Current income taxes are based on the year’s
income taxable for federal and state income tax reporting purposes. Total tax provision may differ from the statutory tax rates applied
to income before provision for income taxes due principally to expenses charged which are not tax deductible.

|                                    |     | December 31, 
 2023         |         |   |     | December 31, 
 2022         |          |   |
|:-----------------------------------|:----|:-------------|:--------|:--|:----|:-------------|:---------|:--|
| Current expense                    |     | $            | (94,819 | ) |     | $            | (599,159 | ) |
| Deferred tax benefit               |     |              | —       |   |     |              | —        |   |
| Change in valuation allowance      |     |              | —       |   |     |              | —        |   |
| Total income tax (expense) benefit |     | $            | (94,819 | ) |     | $            | (599,159 | ) |

|                                             |     |   | December 31, 
         2023 |   |     |   | December 31, 
         2022 |   |
|:--------------------------------------------|:----|:--|-------------:|:--|:----|:--|-------------:|:--|
| Deferred tax assets                         |     | $ |      607,516 |   |     | $ |      596,692 |   |
| Deferred tax liabilities                    |